Immune thrombocytopenia after immune checkpoint inhibitor therapy

被引:4
作者
Amanam, Idoroenyi [1 ]
Gupta, Rohan [2 ]
Pullarkat, Vinod [1 ]
Mei, Matthew [1 ]
机构
[1] City Hope Natl Med Ctr, Dept Hematol & HCT, Duarte, CA 91010 USA
[2] CenterTX, Dallas, TX USA
关键词
D O I
10.1111/bjh.17387
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:677 / 681
页数:5
相关论文
共 37 条
[21]   Autoimmune hemolytic anemia induced by anti-PD-1 therapy in metastatic melanoma [J].
Kong, Benjamin Y. ;
Micklethwaite, Kenneth P. ;
Swaminathan, Sanjay ;
Kefford, Richard F. ;
Carlino, Matteo S. .
MELANOMA RESEARCH, 2016, 26 (02) :202-204
[22]   Prevalence of immune-related systemic adverse events in patients treated with anti-Programmed cell Death 1/anti-Programmed cell Death-Ligand 1 agents: A single-centre pharmacovigilance database analysis [J].
Le Burel, Sebastien ;
Champiat, Stephane ;
Mateus, Christine ;
Marabelle, Aurelien ;
Michot, Jean-Marie ;
Robert, Caroline ;
Belkhir, Rakiba ;
Soria, Jean-Charles ;
Laghouati, Salim ;
Voisin, Anne-Laure ;
Fain, Olivier ;
Mekinian, Arsene ;
Coutte, Laetitia ;
Szwebel, Tali-Anne ;
Dunogeant, Laetitia ;
Lioger, Bertrand ;
Luxembourger, Cecile ;
Mariette, Xavier ;
Lambotte, Olivier .
EUROPEAN JOURNAL OF CANCER, 2017, 82 :34-44
[23]   Two cases of immune thrombocytopenia associated with pembrolizumab [J].
Le Roy, Audrey ;
Kempf, Emmanuelle ;
Ackermann, Felix ;
Routier, Emilie ;
Robert, Caroline ;
Turpin, Anthony ;
Marabelle, Aurelien ;
Mateus, Christine ;
Michot, Jean-Marie ;
Lambotte, Olivier .
EUROPEAN JOURNAL OF CANCER, 2016, 54 :172-174
[24]   A fatal allo- and immune-mediated thrombocytopenia with a PD-L1 inhibitor [J].
Leroy, L. ;
Lafarge, X. ;
Blouin, L. ;
Bijou, F. ;
Durrieu, F. ;
Olivier, E. ;
Le Moulec, S. .
ANNALS OF ONCOLOGY, 2018, 29 (02) :514-515
[25]  
Merck Sharp & Dohme Corp, KEYTRUDA PEMBR
[26]   Aplastic anemia secondary to nivolumab and ipilimumab in a patient with metastatic melanoma: a case report [J].
Meyers, D. E. ;
Hill, W. F. ;
Suo, A. ;
Jimenez-Zepeda, V. ;
Cheng, T. ;
Nixon, N. A. .
EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2018, 7
[27]   Immune-related bone marrow failure following anti-PD1 therapy [J].
Michot, Jean-Marie ;
Vargaftig, Jacques ;
Leduc, Charlotte ;
Quere, Gilles ;
Burroni, Barbara ;
Lazarovici, Julien ;
Champiat, Stephane ;
Ribrag, Vincent ;
Lambotte, Olivier .
EUROPEAN JOURNAL OF CANCER, 2017, 80 :1-4
[28]   High-dose dexamethasone compared with prednisone for previously untreated primary immune thrombocytopenia: a systematic review and meta-analysis [J].
Mithoowani, Siraj ;
Gregory-Miller, Kathleen ;
Goy, Jennifer ;
Miller, Matthew C. ;
Wang, Grace ;
Noroozi, Nastaran ;
Kelton, John G. ;
Arnold, Donald M. .
LANCET HAEMATOLOGY, 2016, 3 (10) :E489-E496
[29]   Immunotherapy-Associated Hemolytic Anemia with Pure Red-Cell Aplasia [J].
Nair, Ranjit ;
Gheith, Shereen ;
Nair, Suresh G. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (11) :1096-1097
[30]   American Society of Hematology 2019 guidelines for immune thrombocytopenia [J].
Neunert, Cindy ;
Terrell, Deirdra R. ;
Arnold, Donald M. ;
Buchanan, George ;
Cines, Douglas B. ;
Cooper, Nichola ;
Cuker, Adam ;
Despotovic, Jenny M. ;
George, James N. ;
Grace, Rachael F. ;
Kuehne, Thomas ;
Kuter, David J. ;
Lim, Wendy ;
McCrae, Keith R. ;
Pruitt, Barbara ;
Shimanek, Hayley ;
Vesely, Sara K. .
BLOOD ADVANCES, 2019, 3 (23) :3829-3866